Cantor Fitzgerald has a “Overweight” rating and a $7.00 price objective on the stock. The consensus estimate for Mereo BioPharma Group’s current full-year earnings is ($0.03) per share. Get ...

Cantor Fitzgerald announces it will be expanding it's Bitcoin financing services in the wake of Trump administration changes. Reflecting the United States’ growing embrace of Bitcoin, investment bank ...

Cantor Fitzgerald currently has a “Overweight” rating and a $46.00 price objective on the stock. The consensus estimate for Sanara MedTech’s current full-year earnings is ($1.10) per share ...

Meeting to be held in San Francisco on March 31 hosted by Cantor Fitzgerald.Light Up your Portfolio with Spark:Easily identify stocks' risks ...

Investment banking firm Cantor Fitzgerald has selected Anchorage Digital and Copper as its Bitcoin custodians and collateral managers as it launches its new digital asset financing business ...

Lucid Group (LCID – Research Report) received a Hold rating and a $3.00 price target from Cantor Fitzgerald analyst Andres Sheppard today. The ...

Since ending in correction territory last week, Wall Street has rebounded, and Cantor Fitzgerald believes this rally could extend through to the end of the month. However, despite the potential ...

Global Head of Cantor Fitzgerald Asset Management. "This growth underscores our commitment to creating lasting economic impact and revitalizing neighborhoods across the United States. We are ...

On Wednesday, Cantor Fitzgerald maintained an Overweight rating on Kalvista Pharmaceuticals Inc (NASDAQ:KALV), following the company’s recent webinar that focused on its launch strategy for ...

Fintel reports that on March 19, 2025, Cantor Fitzgerald upgraded their outlook for Tesla (SNSE:TSLA) from Neutral to Overweight. There are 5,232 funds or institutions reporting positions in Tesla.

On Friday, Cantor Fitzgerald reiterated its Overweight rating on Compass Pathways plc (NASDAQ:CMPS), a life sciences company focused on developing psilocybin therapy for mental health conditions.